Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02690805 · ClinicalTrials.gov registry record
Predicting Neoadjuvant Chemotherapy Response by Using a Combined MRI and Scinti-Mammography (MRI-SMM) System
A clinical trial, sponsored by University of California, Irvine.
- Completed
- Registry status
- 16
- Enrollment target
NCT02690805: Completed study, sponsored by University of California, Irvine.
NCT02690805 is a clinical trial that has completed, run by University of California, Irvine. The registered enrollment target is 16 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02690805 has completed, sponsored by University of California, Irvine.
- COMPLETED
- Registry status
- 16 participants
- Enrollment target
Study Summary
The purpose of this research study is to investigate the accuracy of a breast imaging system that measures the uptake of the injected radioactive tracer by gamma-ray imaging, known as scinti-mammography (SMM), to diagnose the residual breast cancer after neoadjuvant chemotherapy (NAC) treatment by comparing to MRI.
Primary Outcome
Breast cancer patients receiving neoadjuvant chemotherapy will be imaged by a combined MRI and scinti-mammography (MRI-SMM) imaging system, and the diagnostic accuracy as assessed by MRI and SMM will be reported.
Interventions
- DEVICE MR-compatible scinti-mammography (MRI-SMM) system
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2015-05 |
| Est. Completion | 2019-01-25 |
What the finished NCT02690805 record still lists
NCT02690805 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 16 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which MR-compatible scinti-mammography (MRI-SMM) system is the first listed.
NCT02690805 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02690805 about?
NCT02690805 is a clinical study titled "Predicting Neoadjuvant Chemotherapy Response by Using a Combined MRI and Scinti-Mammography (MRI-SMM) System". The purpose of this research study is to investigate the accuracy of a breast imaging system that measures the uptake of the injected radioactive tracer by gamma-ray imaging, known as scinti-mammography (SMM), to diagnose the residual breast cancer after neoadjuvant chemotherapy (NAC) treatment by c...
What is the current status of trial NCT02690805?
This trial is currently completed. The enrollment target is 16 participants. The study started on 2015-05. Estimated completion is 2019-01-25.
What interventions are being tested in trial NCT02690805?
The interventions under investigation include: MR-compatible scinti-mammography (MRI-SMM) system (DEVICE).
Who is sponsoring clinical trial NCT02690805?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia